Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 4651 (miR-4651) is a small non-coding single-stranded RNA (approximately 18–24 nucleotides) encoded on chromosome 7, functioning as a post-transcriptional regulator of gene expression. It is downregulated in hepatocellular carcinoma (HCC), and its overexpression suppresses tumor cell growth and promotes apoptosis, in part by directly targeting and downregulating forkhead box protein P4 (FOXP4). miR-4651 is also suggested to act as a tumor suppressor and potential prognostic biomarker for HCC progression[1]. No drugs are currently in clinical use directly targeting miR-4651, but chemically modified oligonucleotide inhibitors are commercially available for research purposes[2].
Not applicable for direct drugs; miR-4651 acts by binding to target mRNAs and repressing gene expression, primarily via translational inhibition or mRNA degradation[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 4651 (miR-4651).